Intravascular hemolysis as a complication of clostridium perfringens sepsis.
McArthur
Heather L
HL
Division of Medical Oncology, British Columbia Cancer Agency-Vancouver Cancer Centre, and Vancouver General Hospital, Vancouver, BC, Canada.
Dalal
Bakul I
BI
Kollmannsberger
Christian
C
D000743:Anemia, Hemolytic / Q000209:etiology / Q000382:microbiology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D016470:Bacteremia / Q000209:etiology / Q000382:microbiology; D018288:Carcinoma, Small Cell / Q000150:complications / Q000188:drug therapy; D002945:Cisplatin / Q000008:administration & dosage; D003015:Clostridium Infections / Q000150:complications*; D003016:Clostridium perfringens / Q000302:isolation & purification*; D005047:Etoposide / Q000008:administration & dosage; D006461:Hemolysis; D006801:Humans; D041781:Jaundice, Obstructive / Q000209:etiology; D008113:Liver Neoplasms / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000150:complications / Q000188:drug therapy; D010190:Pancreatic Neoplasms / Q000150:complications* / Q000188:drug therapy; D018746:Systemic Inflammatory Response Syndrome / Q000209:etiology / Q000382:microbiology*
D005047:Etoposide; D002945:Cisplatin